Scientists from Cambridge University were able to 'reprogramme' skin cells from individuals with the genetic form of the debilitative disease, in order to mimic the condition. Dr Simon Ridley, Head of Research at Alzheimer's Research UK, which funded the study, said: "We are pleased to see that our investment in this innovative research using stem cell technology is boosting our understanding of Alzheimer's disease mechanisms."
http://ift.tt/1bkdvUX
No comments:
Post a Comment